Inventor · disambiguated record
Thomas H. Graham
Also filed as: GRAHAM THOMAS H
30 granted patents·12 pending applications·44 citations·filing 2011–2025
94Inventor score
Files withMERCK SHARP & DOHME24MERCK SHARP & DOHME LLC13GRAHAM THOMAS H2BOYCE CHRISTOPHER W1SHEN DONG-MING1
Top patents by PatentIndex Score
42 records- 0193US11697657B2Small molecule inhibitors of KRAS G12C mutantMERCK SHARP & DOHME LLC·Filed 2020·Granted Jul 11, 2023·4 cites·22 claims
- 0293US10479801B2Tetracyclic heterocycle compounds useful as HIV integrase inhibitorsMERCK SHARP & DOHME·Filed 2017·Granted Nov 19, 2019·7 cites·39 claims
- 0389US10947222B2Indole derivatives useful as inhibitors of diacylglyceride O-acyltransferase 2MERCK SHARP & DOHME·Filed 2017·Granted Mar 16, 2021·6 cites·13 claims
- 0488US11312719B29-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their useMERCK SHARP & DOHME·Filed 2019·Granted Apr 26, 2022·4 cites·25 claims
- 0584US11104690B2Indazole derivatives useful as inhibitors of diacylglyceride O-acyltransferase 2MERCK SHARP & DOHME·Filed 2017·Granted Aug 31, 2021·4 cites·9 claims
- 0683US10150780B2Spirocyclic heterocycle compounds useful as HIV integrase inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Dec 11, 2018·3 cites·15 claims
- 0782US10829499B2Tetracyclic heterocycle compounds useful as HIV integrase inhibitorsMERCK SHARP & DOHME·Filed 2019·Granted Nov 10, 2020·1 cites·14 claims
- 0881US12297208B2Small molecule inhibitors of KRAS G12C mutantMERCK SHARP & DOHME LLC·Filed 2023·Granted May 13, 2025·0 cites·18 claims
- 0981US12291538B2Small molecule inhibitors of KRAS G12C mutantMERCK SHARP & DOHME LLC·Filed 2023·Granted May 6, 2025·0 cites·6 claims
- 1081US12263171B27-, 8-, and 10-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their useMERCK SHARP & DOHME LLC·Filed 2019·Granted Apr 1, 2025·2 cites·20 claims
- 1181US9643982B2Fused tricyclic heterocyclic compounds as HIV integrase inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted May 9, 2017·3 cites·14 claims
- 1278US11161854B2Indazolyl-spiro[2.2]pentane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereofMERCK SHARP & DOHME·Filed 2018·Granted Nov 2, 2021·2 cites·10 claims
- 1378US9861620B2Substituted quinolizine derivatives useful as HIV integrase inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Jan 9, 2018·3 cites·27 claims
- 1476US10201533B2Substituted quinolizine derivatives useful as HIV integrase inhibitorsMERCK SHARP & DOHME·Filed 2017·Granted Feb 12, 2019·1 cites·11 claims
- 1576US9707234B2Spirocyclic hetercycle compounds useful as HIV integrase inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Jul 18, 2017·2 cites·19 claims
- 1674US9714243B24-pyridinonetriazine derivatives as HIV integrase inhibitorsMERCK SHARP & DOHME·Filed 2013·Granted Jul 25, 2017·1 cites·19 claims
- 1772US2025382300A1Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their useMERCK SHARP & DOHME LLC·Filed 2025·Application pending·0 cites
- 1871US12060357B29-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their useMERCK SHARP & DOHME LLC·Filed 2022·Granted Aug 13, 2024·0 cites·28 claims
- 1969US10221186B2Spirocyclic heterocyclic compounds useful as HIV integrase inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Mar 5, 2019·1 cites·13 claims
- 2069US2025387397A1Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their useMERCK SHARP & DOHME LLC·Filed 2025·Application pending·0 cites
- 2169US2021040096A1Fused tricyclic heterocyclic compounds as hiv integrase inhibitorsMERCK SHARP & DOHME·Filed 2020·Application pending·0 cites
- 2267US11358711B2Tetracyclic heterocycle compounds useful as HIV integrase inhibitorsMERCK SHARP & DOHME·Filed 2020·Granted Jun 14, 2022·0 cites·14 claims
- 2362US2019322666A1Fused tricyclic heterocyclic compounds as hiv integrase inhibitorsMERCK SHARP & DOHME·Filed 2019·Application pending·0 cites
- 2461US12414952B2Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their useMERCK SHARP & DOHME LLC·Filed 2019·Granted Sep 16, 2025·0 cites·10 claims
- 2560US12466831B2Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their useMERCK SHARP & DOHME LLC·Filed 2019·Granted Nov 11, 2025·0 cites·14 claims
- 2658US2018099967A1Fused tricyclic heterocyclic compounds as hiv integrase inhibitorsMERCK SHARP & DOHME·Filed 2017·Application pending·0 cites
- 2756US2024262842A1Small molecule inhibitors of kras g12c mutantMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 2856US2024246968A1Small molecule inhibitors of kras g12c mutantMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 2954US2024076297A1Adenosine a2a and a2b receptor dual antagonists for immuno-oncologyMERCK SHARP & DOHME LLC·Filed 2021·Application pending·0 cites
- 3054US2017190701A1Fused tricyclic heterocyclic compounds as hiv integrase inhibitorsYU TAO·Filed 2016·Application pending·0 cites
- 3154US2024239788A1Small molecule inhibitors of kras g12d mutantMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 3253US2023322785A1Adenosine a2a and a2b receptor dual antagonists for immuno-oncologyBOYCE CHRISTOPHER W·Filed 2022·Application pending·0 cites
- 3349US2022402916A1Small molecule inhibitors of kras g12c mutantMERCK SHARP & DOHME·Filed 2020·Application pending·0 cites
- 3448US9493479B2Substituted pyrido[1,2-a]pyrazines as HIV integrase inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Nov 15, 2016·0 cites·12 claims
- 3547US10934312B2Tricyclic heterocycle compounds useful as HIV integrase inhibitorsMERCK SHARP & DOHME·Filed 2017·Granted Mar 2, 2021·0 cites·17 claims
- 3643US10548910B2Amido-substituted pyridotriazine derivatives useful as HIV integrase inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Feb 4, 2020·0 cites·16 claims
- 3743US10233193B2Fused tricyclic heterocyclic compounds useful for treating HIV infectionMERCK SHARP & DOHME·Filed 2016·Granted Mar 19, 2019·0 cites·19 claims
- 3842US10081647B2Phosphate substituted quinolizine derivatives useful as HIV integrase inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Sep 25, 2018·0 cites·21 claims
- 3941US10624912B2Spirocyclic Pyridotriazine Derivatives useful as HIV integrase inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Apr 21, 2020·0 cites·15 claims
- 4036US8669252B2Prolylcarboxypeptidase inhibitorsSHEN DONG-MING·Filed 2011·Granted Mar 11, 2014·0 cites·19 claims
- 4134US8569299B2Prolylcarboxypeptidase inhibitorsGRAHAM THOMAS H·Filed 2011·Granted Oct 29, 2013·0 cites·22 claims
- 4232US8921394B2Prolylcarboxypeptidase inhibitorsGRAHAM THOMAS H·Filed 2011·Granted Dec 30, 2014·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Thomas H. Graham files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →